SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to fresh 52-week highs has traders focused on the upcoming Q3 report and whether BRIUMVIs sales growth will support the move. Buyout and short-squeeze speculation is adding to the bullish chatter, but no deal is confirmed.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave shares are drawing attention amid a steep selloff and repeated lows, with traders debating whether the decline reflects broad weakness in speculative quantum stocks or concerns about high valuations, losses, and the distance to commercial profitability. Bearish sentiment is prominent, though some investors view the drop as a buying opportunity; the upcoming quarterly report is seen by some as a test of the business case.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

A Northland upgrade citing C3 Code as a potential growth driver for agentic AI has renewed interest in C3.ai, alongside unusual call-option activity and short-squeeze speculation. Traders are divided between optimism about the product and enterprise AI demand, and concern over declining revenue and continued losses.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyvernas durable one-year miv-cel results in stiff-person syndrome, alongside longer-term myasthenia gravis data, are driving discussion as the company advances its rolling BLA for SPS. Traders are split: some see the findings as strengthening the case for approval, while others cite the stocks weak reaction, small study sizes, safety questions and possible dilution as reasons for caution.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in London, Canada.

Aduro Clean Technologies Inc

Aduros reported pilot results showing high condensable-hydrocarbon yields across polypropylene and mixed polyolefin feeds are driving discussion, alongside progress toward its planned first-of-a-kind facility. Bulls see the results and engineering work as validation of its plastics-recycling technology, while skeptics argue that yields do not establish commercial economics or scalability.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomms sharp decline is being discussed mainly as part of a broad semiconductor selloff following Intels weak outlook, with traders also noting bearish put-heavy options activity. The community is split between treating the drop as a buying opportunity and worrying about further downside ahead of Qualcomms earnings report.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

Attention centers on REalloys role in a North American rare-earth and magnet supply chain, including its Army-linked Tooele opportunity, Tanbreez offtake, and expected 2027 defense sourcing restrictions. Bulls see a strategic demand tailwind and speculate about a short squeeze, while bears point to volatility, limited company updates, and execution risks.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Reports that Innodata laid off roughly 550 workers in India, with additional cuts reported in the Philippines, have fueled concern that a client project was scaled back and could affect revenue. Traders disagree over whether the cuts signal lost customer work or operational efficiency, and are looking to management and quarterly results for clarification.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

Discussion is focused on onsemis emerging AI/data-center exposure: traders point to growth in the Other end-market category, which includes computing and data centers, but question how durable that demand is because long-term supply agreements can be changed or canceled. The debate is tempered by the companys continued exposure to automotive and industrial markets facing a cyclical slowdown, alongside the stocks recent weakness.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Berkshire Hathaways large disclosed stake in Lennar has drawn attention, with bulls viewing the buying as a vote of confidence while others question whether it signals a bottom. The bullish case is offset by weak results and a lowered delivery outlook amid high mortgage rates, plus Hunterbrooks allegations about Lennars transactions with its Millrose spinoff, which have raised concerns among traders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Balchem: 3 Key Takeaways for Long-Term Investors

Key PointsThird-quarter net sales rose 8.6% year over year to $291 million...

Balchem Q3 2026 Earnings Call Transcript

Balchem (NASDAQ:BCPC) reported third-quarter financial results on Friday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

Balchem Corp. Q3 Income Rises

(RTTNews) - Balchem Corp. (BCPC) released a profit for its third quarter that Increases, from the same period last year...

Balchem Corp.'s (BCPC) 8% Top-Line Growth Proves Resilience Amid Macro Risk

Balchem Corp.'s (BCPC) 8% Top-Line Growth Proves Resilience Amid Macro Risk...

Quaker Chemical (KWR) Q2 Earnings and Revenues Surpass Estimates

Quaker Chemical (KWR) delivered earnings and revenue surprises of +30.36% and +4.05%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Sensient Technologies (SXT) Surpasses Q2 Earnings and Revenue Estimates

Sensient (SXT) delivered earnings and revenue surprises of +20.00% and +4.00%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Hudbay Minerals Expands Constancia Mill Capacity With Permit Approval 

HBM secures approval to boost Constancia's mill capacity to 34 million tons annually, extending mine life and supporting infrastructure upgrades.

BASFY and Bota Launch AI-Powered Collagen III for Personal Care

BASF's AI-powered SkinNexus Collag3n launch with Bota brings vegan, human-identical collagen to personal care after strong lab and clinical results.

Avient Launches Non-PFAS Barrier Technology for HDPE Packaging

AVNT's Cesa Solvent Barrier Technology gives HDPE bottles a non-PFAS way to hold aggressive solvents without reworking existing molding lines.

BASFY Adds Certified Sulfite Grades to North American Portfolio

BASF expands its North American water treatment lineup with certified sulfite grades, boosting supply flexibility and product support.

• Reported GAAP EPS of $1.57 up 16.30% YoY
• Reported revenue of $290.66M up 8.63% YoY

Balchem reported higher manufacturing input costs that partially offset sales growth, favorable mix and manufacturing efficiencies; compensation-related costs increased, and inventories were $177.01M versus $131.45M at December 31, 2025.

Balchem recorded sales and operating-earnings growth across all three segments, highlighted its science-backed innovation pipeline, and repurchased approximately $28M of common stock during Q3 2026.

Balchem Corp. markets specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in 1967 and is headquartered in Montvale, NJ.

Balchem Corp.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$169.98
Prev Close	$170.40
Open	$172.89
Dividend Yield	0.63%
50-Day Moving Average	$170.17
Beta	0.59
Avg. Volume	215,539.17
PE Ratio	32.04

52-Week High	$183.90
52-Week Low	$147.18
Market Capitalization	$5.4B
EPS (Annual)	$4.75
Price to Book	4.08
Revenue Per Employee	$767,130.92

Feed

News

Sentiment

Earnings

Fundamentals

Info

BCPC Fundamentals